WASHINGTON, United States (AFP) — US biotech firm Novavax on Monday said it had positive results from preclinical studies of a shot combining its influenza and Covid vaccine candidates. The company said a study, which it has posted to a preprint server and will now undergo peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters. “Despite low rates during the Covid-19 pandemic, influenza remains a significant […]